This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
KiOR: Catalyzing Clean Energy
Nanda, Ramana; Stuart, TobyCase HBS-809092-EEntrepreneurshipBiofuels start-up KiOR was developing a proprietary technology that had the potential to dramatically impact the emerging renewable energy landscape: a process that converted cellulosic biomass into "bio-crude," a hydrocarbon mixture with properties to those of crude oil. KiOR had been operating as a virtual organization, but with venture financing in place, founder and chief technology officer Paul O'Connor and the KiOR board needed to decide wh...Starting at €8.20
-
Tennant Company
Stuart, Toby; Applegate, Lynda M.; Weber, JamesCase HBS-810040-EEntrepreneurshipTennant, a leading producer of floor cleaning equipment, must determine how to create, finance, structure, staff, govern, measure and manage a new venture for developing a fundamentally new product line. In 2005, Tennant Company had developed an innovative, environmentally friendly, cleaning technology that could potentially revolutionize cleaning. Historically, Tennant was a producer of floor and carpet washing machines for industrial and commer...Starting at €8.20
-
Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)
Stuart, Toby; Webber, JamesCase HBS-813029-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
Katerra
Leslie, Mark; Saucedo, MattCase SGSB-E655-EEntrepreneurshipThe Katerra case takes a deep dive into the opportunities to leverage disruptive technology in the global construction industry. The case analyzes the history of Katerra, a technology-driven offsite construction company and walks through each of the company’s major strengths and opportunitiesStarting at €8.20
-
Note on IPO Share Allocation
Leslie, Mark; Marks, Michael; Magat Raffaelli, ClaireCase SGSB-E377-EEntrepreneurshipAn initial public offering (IPO) is the first sale of stock or shares by a company to the public. IPOs are often issued by smaller, younger companies seeking capital to expand, although they can also be done by large privately owned companies looking to become publicly traded. When a company lists its shares on a public exchange it will almost always issue additional new shares at the same time. The money paid by investors for the newly issued...Starting at €8.20
-
Sirtris Pharmaceuticals: Living Healthier, Longer
Stuart, Toby; Kiron, DavidCase HBS-808112-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, Early stage bio-pharmaceuticals company.l Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
GSK's Acquisition of Sirtris: Independence or Integration, Teaching Note
Stuart, TobyTeaching Note HBS-811012-EEntrepreneurshipTeaching Note for 809026.Starting at €0.00
-
GSK's Acquisition of Sirtris: Independence or Integration
Stuart, Toby; Weber, JamesCase HBS-809026-EEntrepreneurshipAn executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's Global head of R&D, championed the acquisition of Sirtris to gain access to its potentially revolutionary science. Slaoui must balance the need to recoup shareholder value after paying a two-times premium for Sirtris with his desire to retain Christoph Westphal, Sirtris's co-founder and CEO, and othe...Starting at €8.20
-
Sirtis Pharmaceuticals: Living Healthier, Longer, Teaching Note
Stuart, TobyTeaching Note HBS-809050-EEntrepreneurshipTeaching Note for [808-112].Starting at €0.00
-
Incept LLC and Confluent Surgical (A)
Chakravorti, Bhaskar; Stuart, Toby; Weber, JamesCase HBS-809062-EEntrepreneurshipTo maximize their effectiveness, color cases should be printed in color. A venture capitalist must decide whether to invest in a medical technology company that licenses intellectual property from a privately held IP holding company based on a platform technology. Entrepreneurs Amar Sawhney and Fred Khosravi founded Incept LLC to commercialize their multi-use hydrogel technology. The pair then spun off Confluent Surgical to develop some, but not ...Starting at €8.20